Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization

Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2021
Materias:
Acceso en línea:https://doaj.org/article/ca54115097ca404abb834a9b50fca39c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ca54115097ca404abb834a9b50fca39c
record_format dspace
spelling oai:doaj.org-article:ca54115097ca404abb834a9b50fca39c2021-12-04T16:04:21ZOptimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization10.15420/usc.2020.291758-390X1758-3896https://doaj.org/article/ca54115097ca404abb834a9b50fca39c2021-04-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2020.29https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XHeart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are not receiving one or more of the recommended medications, often due to suboptimal initiation and titration in the outpatient setting. Hospitalization serves as a key point to initiate and titrate GDMT. Four evidence-based therapies have clinical benefit within 30 days of initiation and form a crucial foundation for HFrEF therapy: renin-angiotensin-aldosterone system inhibitors with or without a neprilysin inhibitor, β-blockers, mineralocorticoid-receptor-antagonists, and sodium-glucose cotransporter-2 inhibitors. The authors present a practical guide for the implementation of these four pillars of GDMT during a hospitalization for acute heart failure.Neal M DixitShivani ShahBoback ZiaeianGregg C FonarowJeffrey J HsuRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 15, Iss , Pp - (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Neal M Dixit
Shivani Shah
Boback Ziaeian
Gregg C Fonarow
Jeffrey J Hsu
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
description Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are not receiving one or more of the recommended medications, often due to suboptimal initiation and titration in the outpatient setting. Hospitalization serves as a key point to initiate and titrate GDMT. Four evidence-based therapies have clinical benefit within 30 days of initiation and form a crucial foundation for HFrEF therapy: renin-angiotensin-aldosterone system inhibitors with or without a neprilysin inhibitor, β-blockers, mineralocorticoid-receptor-antagonists, and sodium-glucose cotransporter-2 inhibitors. The authors present a practical guide for the implementation of these four pillars of GDMT during a hospitalization for acute heart failure.
format article
author Neal M Dixit
Shivani Shah
Boback Ziaeian
Gregg C Fonarow
Jeffrey J Hsu
author_facet Neal M Dixit
Shivani Shah
Boback Ziaeian
Gregg C Fonarow
Jeffrey J Hsu
author_sort Neal M Dixit
title Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
title_short Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
title_full Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
title_fullStr Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
title_full_unstemmed Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
title_sort optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization
publisher Radcliffe Medical Media
publishDate 2021
url https://doaj.org/article/ca54115097ca404abb834a9b50fca39c
work_keys_str_mv AT nealmdixit optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization
AT shivanishah optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization
AT bobackziaeian optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization
AT greggcfonarow optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization
AT jeffreyjhsu optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization
_version_ 1718372700857040896